NAD+ 1000mg & Tirzepatide's Successor : A British News
The recent interest in NAD+ supplementation, particularly at a high dosage of 1000mg , continues to rise within the British medical community. Concurrently, attention is focused on Retatrutide, a groundbreaking GLP-1 analogue being viewed by many as a potential successor to Tirzepatide. At presen